Share on LinkedInShare on LinkedIn

ARTICLE · 07 FEBRUARY 2022

COVID-19 Key EU Developments, Policy & Regulatory Update No. 73

Jones Day
Jones Day
Contributor
Jones Day

Jones Day

Jones Day is a global law firm with more than 2,400 lawyers in 40 offices across five continents....

View firm profile
Explore more from Jones Day

This regular update (no. 73 | 17 January 2022) covers key regulatory EU developments related to the evolving COVID-19 situation

European UnionCoronavirus (COVID-19)

LATEST KEY DEVELOPMENTS

Competition & State Aid

  • Commission publishes Competition Policy – 2021 at a glance
  • European Commission approves new and amended Member State measures to support the economy

Trade / Export Controls

  • European Investment Bank releases Investment Report 2021/2022 Medicines and Medical Devices
  • EMA recommendations to update product information on COVID-19 Vaccines Janssen and Vaxzevria
  • EMA launches initiative on Accelerating Clinical Trials in the EU
  • EMA announces regulators discussion on global regulatory response to COVID-19 Omicron variant
  • EMA publishes findings on continuous monitoring of data on effectiveness of vaccines against COVID-19

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from